Auditory late effects of chemotherapy.
Meyer
Anna K
AK
Division of Pediatric Otolaryngology, Department of Otolaryngology - Head & Neck Surgery, University of California, San Francisco, San Francisco, CA 94143-0342, USA. annakatrinemeyer@gmail.com
Young
Nancy M
NM
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D004999:Amifostine / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy; D002648:Child; D016371:Cranial Irradiation / Q000009:adverse effects; D004307:Dose-Response Relationship, Radiation; D006311:Hearing Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D023421:Models, Animal; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use; D011832:Radiation Injuries / Q000453:epidemiology / Q000209:etiology; D011879:Radiotherapy Dosage; D017741:Survivors; D013885:Thiosulfates / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use; D055815:Young Adult
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D013885:Thiosulfates; D014750:Vincristine; C017717:sodium thiosulfate; D004999:Amifostine